Muraro A, Hoekstra MO, Meijer Y, Lifschitz C, Wampler JL, Harris C, Scalabrin DMF. Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial.
BMJ Open 2012;
2:e000637. [PMID:
22396223 PMCID:
PMC3298831 DOI:
10.1136/bmjopen-2011-000637]
[Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
OBJECTIVE
To evaluate the hypoallergenicity of an extensively hydrolysed (EH) casein formula supplemented with Lactobacillus rhamnosus GG (LGG).
DESIGN
A prospective, randomised, double-blind, placebo-controlled crossover trial.
SETTING
Two study sites in Italy and The Netherlands.
STUDY PARTICIPANTS
Children with documented cow's milk allergy were eligible for inclusion in this trial.
INTERVENTIONS
After a 7-day period of strict avoidance of cow's milk protein and other suspected food allergens, participants were tested with an EH casein formula with demonstrated hypoallergenicity (control, EHF) and a formula of the same composition with LGG added at 10(8) colony-forming units per gram powder (EHF-LGG) in randomised order in a double-blind placebo-controlled food challenge (DBPCFC). After absence of adverse reactions in the DBPCFC, an open challenge was performed with EHF-LGG, followed by a 7-day home feeding period with the same formula.
MAIN OUTCOME MEASURE
Clinical assessment of any adverse reactions to ingestion of study formulae during the DBPCFC.
RESULTS
For all participants with confirmed cow's milk allergy (n=31), the DBPCFC and open challenge were classified as negative.
CONCLUSION
The EH casein formula supplemented with LGG is hypoallergenic and can be recommended for infants and children allergic to cow's milk who require an alternative to formulae containing intact cow's milk protein.
TRIAL REGISTRATION NUMBER
http://ClinicalTrials.gov Identifier: NCT01181297.
Collapse